4-81-75
| 规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
|---|---|---|---|---|---|---|---|---|---|
| 1g | ￥ ǬĽǑLJLJ | > 1 | > 1 | 1 | -- | -- | 1 | ￥ ǬĽǑLJLJ | - + |
| 5g | ￥ ĽƑǑLJLJ | > 1 | 5 | 6 | 4 | ￥ ĽƑǑLJLJ | - + | ||
| 1g | ￥ řȖǑLJLJ | 1 | > 1 | -- | 1 | ￥ řȖǑLJLJ | - + | ||
| 5g | ￥ īũƄǑLJLJ | -- | > 1 | -- | 4 | ￥ īũƄǑLJLJ | - + | ||
| 1g | ￥ řƄīǑLJLJ | -- | > 1 | -- | 4 | ￥ řƄīǑLJLJ | - + | ||
| 5g | ￥ ĽǬLJƄǑLJLJ | -- | -- | -- | -- | -- | ￥ ĽǬLJƄǑLJLJ | - + | |
| 1kg | ￥ řƄũũǑLJLJ | -- | 1 | -- | -- | -- | -- | ￥ řƄũũǑLJLJ | - + |
| 大货 | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
64.9
[1]. Maarten J Titulaer, et al. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lancet Neurol. 11 Dec;1(1):198-17.
[]. Ojala KS, et al. A high-affinity, partial antagonist effect of ,4-diaminopyridine mediates action potential broadening and enhancement of transmitter release at NMJs. J Biol Chem. 1 Jan-Jun;96:1.
[]. T L Harris, et al. Lycopodium clavatum exine microcapsules enable safe oral delivery of ,4-diaminopyridine for treatment of botulinum neurotoxin A intoxication. Chem Commun (Camb). 16 Mar 18;5():4187-9.
[4]. A Quartel, et al. Current therapy for Lambert-Eaton myasthenic syndrome: development of ,4-diaminopyridine phosphate salt as first-line symptomatic treatment. Curr Med Res Opin. 1 Jun;6(6):16-75.
[5]. Adrian Quartel, et al. Orphan drugs. BioMarin Europe replies. BMJ. 1 Dec 7:41:c76.
H+H-H11-H19
P6-P64-P7-P71-P8-P84-P+P5-P4+P4-P-P61+P64-P45-P51
GHS6
811
11668 现货
￥ řīǑLJLJ -1mg
116895 现货
￥ ũũũřǑLJLJ -1mg
141 货期咨询
￥ ƑLJƑǑLJLJ -1g
16911 货期咨询
￥ ƑƄũǑLJLJ -1g
179788 货期咨询
￥ ĽǜīřǑLJLJ -1g
1877 货期咨询
￥ ǜȖũǑLJLJ -mg
5417 货期咨询
151884 货期咨询
￥ ƑLJǑLJLJ -5g
16896 货期咨询
￥ ǬLJřǑLJLJ -1mg
18441 货期咨询
￥ īƄũǑLJLJ -1mg
沪ICP备1719645号
